Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros


Bases de datos
Año de publicación
Tipo del documento
Intervalo de año de publicación
1.
Indian J Med Microbiol ; 40(4): 590-592, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35820982

RESUMEN

Leprosy is caused by Mycobacterium leprae (M. leprae) and is unique in terms of the chronicity of the disease and its prolonged treatment protocol. Even after the introduction of multidrug therapy (MDT) by World health organization (WHO), large numbers of new cases (nearly 200,000) of leprosy are reported yearly, indicating active transmission, especially in developing countries. Recurrent clinical manifestations after MDT can occur due to leprosy reactions, relapse or reinfection. It is very difficult to differentiate reaction, relapse and reinfection. Here we categorized a recent case of reoccurrence of leprosy as reinfection by differentiating it from reaction and relapse based on evidence and by analysing the clinical data of the patient.


Asunto(s)
Leprostáticos , Lepra , Diagnóstico Diferencial , Quimioterapia Combinada , Humanos , Leprostáticos/uso terapéutico , Lepra/diagnóstico , Lepra/tratamiento farmacológico , Lepra/microbiología , Mycobacterium leprae/genética , Recurrencia , Reinfección
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA